Won Jong Kim

Title: Innovations by Won Jong Kim in RNA Delivery Systems

Introduction

Won Jong Kim is an accomplished inventor based in Salt Lake City, UT. He has made significant contributions to the field of biotechnology, particularly in the development of innovative delivery systems for small interfering RNA (siRNA). With a total of two patents to his name, Kim's work is paving the way for advancements in cancer treatment.

Latest Patents

Kim's latest patents focus on a polymeric carrier designed for the effective delivery of siRNA into cells. The carrier features a cholesterol residue that is covalently bonded to oligoarginine. By mixing the siRNA with this carrier, a complex-containing composition is produced. When this composition is introduced to a cell, it facilitates the delivery of siRNA into the cell. Notably, the delivery of siRNA targeted to vascular endothelial growth factor represents a promising treatment for cancer. The patents also disclose methods for creating the carrier and the complex.

Career Highlights

Kim is affiliated with the University of Utah Research Foundation, where he continues to explore innovative solutions in the field of RNA delivery. His research is instrumental in advancing therapeutic strategies that could significantly impact cancer treatment.

Collaborations

Kim collaborates with fellow researcher Sung Wan Kim, enhancing the scope and depth of their research endeavors.

Conclusion

Won Jong Kim's innovative work in the development of siRNA delivery systems showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his patents reflect the potential for significant breakthroughs in treatment methodologies.